Opinion on the impact of non-monotonic ...
Type de document :
Article dans une revue scientifique: Article original
DOI :
PMID :
URL permanente :
Titre :
Opinion on the impact of non-monotonic dose responses on EFSA's human health risk assessments.
Auteur(s) :
More, S. [Auteur]
European Food Safety Authority [EFSA]
Benford, D. [Auteur]
Hougaard Bennekou, S. [Auteur]
Bampidis, V. [Auteur]
European Food Safety Authority [EFSA]
Bragard, C. [Auteur]
Halldorsson, T. [Auteur]
Hernandez-Jerez, A. [Auteur]
Koutsoumanis, K. [Auteur]
Lambré, C. [Auteur]
European Food Safety Authority [EFSA]
Machera, K. [Auteur]
Mullins, E. [Auteur]
Nielsen, S. S. [Auteur]
Schlatter, J. [Auteur]
Schrenk, D. [Auteur]
Turck, Dominique [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Tarazona, J. [Auteur]
Younes, M. [Auteur]
European Food Safety Authority [EFSA]
Benford, D. [Auteur]
Hougaard Bennekou, S. [Auteur]
Bampidis, V. [Auteur]
European Food Safety Authority [EFSA]
Bragard, C. [Auteur]
Halldorsson, T. [Auteur]
Hernandez-Jerez, A. [Auteur]
Koutsoumanis, K. [Auteur]
Lambré, C. [Auteur]
European Food Safety Authority [EFSA]
Machera, K. [Auteur]
Mullins, E. [Auteur]
Nielsen, S. S. [Auteur]
Schlatter, J. [Auteur]
Schrenk, D. [Auteur]
Turck, Dominique [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Tarazona, J. [Auteur]
Younes, M. [Auteur]
Titre de la revue :
EFSA Journal
Nom court de la revue :
EFSA J
Numéro :
19
Pagination :
e06877
Date de publication :
2021-11-06
ISSN :
1831-4732
Mot(s)-clé(s) en anglais :
non-monotonic dose response (NMDR)
statistical analysis
probabilistic analysis
biological relevance
reference dose
human health risk assessment
statistical analysis
probabilistic analysis
biological relevance
reference dose
human health risk assessment
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
This Opinion assesses the biological relevance of the non-monotonic dose responses (NMDR) identifiedin a previous EFSA External Report (Beausoleil et al., 2016) produced under GP/EFSA/SCER/2014/01and the follow-up probabilistic ...
Lire la suite >This Opinion assesses the biological relevance of the non-monotonic dose responses (NMDR) identifiedin a previous EFSA External Report (Beausoleil et al., 2016) produced under GP/EFSA/SCER/2014/01and the follow-up probabilistic assessment (Chevillotte et al., 2017a,b), focusing on thein vivodatasets fulfilling most of the checkpoints of the visual/statistical-based analysis identified in Beausoleilet al. (2016). The evaluation was completed with cases discussed in EFSA assessments and the updateof the scientific literature. Observations of NMDR were confirmed in certain studies and are particularlyrelevant for receptor-mediated effects. Based on the results of the evaluation, the Opinion proposes anapproach to be applied during the risk assessment process when apparent non-monotonicity isobserved, also providing advice on specific elements to be considered to facilitate the assessment ofNMDR in EFSA risk assessments. The proposed approach was applied to two case studies, BisphenolA and bis(2-ethylhexyl phthalate (DEHP) and these evaluations are reported in dedicated annexes.Considering the potential impact of NMDRs in regulatory risk assessment, the Scientific Committeerecommends a concerted international effort on developing internationally agreed guidance andharmonised frameworks for identifying and addressing NMDRs in the risk assessment processLire moins >
Lire la suite >This Opinion assesses the biological relevance of the non-monotonic dose responses (NMDR) identifiedin a previous EFSA External Report (Beausoleil et al., 2016) produced under GP/EFSA/SCER/2014/01and the follow-up probabilistic assessment (Chevillotte et al., 2017a,b), focusing on thein vivodatasets fulfilling most of the checkpoints of the visual/statistical-based analysis identified in Beausoleilet al. (2016). The evaluation was completed with cases discussed in EFSA assessments and the updateof the scientific literature. Observations of NMDR were confirmed in certain studies and are particularlyrelevant for receptor-mediated effects. Based on the results of the evaluation, the Opinion proposes anapproach to be applied during the risk assessment process when apparent non-monotonicity isobserved, also providing advice on specific elements to be considered to facilitate the assessment ofNMDR in EFSA risk assessments. The proposed approach was applied to two case studies, BisphenolA and bis(2-ethylhexyl phthalate (DEHP) and these evaluations are reported in dedicated annexes.Considering the potential impact of NMDRs in regulatory risk assessment, the Scientific Committeerecommends a concerted international effort on developing internationally agreed guidance andharmonised frameworks for identifying and addressing NMDRs in the risk assessment processLire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Date de dépôt :
2024-01-12T05:46:22Z
2024-02-27T16:19:33Z
2024-02-27T16:19:33Z
Fichiers
- EFSA Journal - 2021 - - Opinion on the impact of non‐monotonic dose responses on EFSA s human health risk assessments.pdf
- Version éditeur
- Accès libre
- Accéder au document